Position in OGN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$16,865,257
-$3,803,989 QoQ
Shares Held
1,245,588
-63.9% QoQ
Ownership
0.474%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#36
of 626 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $6,352,612,055 across 16 Drug Manufacturers - General names. OGN ranks #13 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
27,357,486 | $1,576,338,337 | |
| 2 | LLY |
ELI LILLY & Co
|
1,035,605 | $1,242,135,802 | |
| 3 | MRK |
Merck & Co., Inc.
|
8,134,262 | $1,045,252,665 | |
| 4 | JNJ |
Johnson & Johnson
|
2,907,803 | $738,494,723 | |
| 5 | ABBV |
AbbVie Inc.
|
2,015,238 | $507,114,486 | |
| 6 | PFE |
Pfizer Inc
|
18,557,891 | $446,874,011 | |
| 7 | BIIB |
Biogen Inc.
|
1,936,859 | $418,477,751 | |
| 8 | AMGN |
Amgen Inc
|
300,007 | $108,638,532 |
All Filings in OGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,865,257 | 1,245,588 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $20,669,246 | 3,450,626 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $61,453,766 | 8,570,958 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $44,601,217 | 4,176,144 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $31,507,275 | 3,254,884 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $20,527,649 | 1,378,620 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $21,516,951 | 1,442,155 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $47,340,818 | 2,474,690 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $71,904,657 | 3,473,655 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $46,723,996 | 2,485,319 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $33,521,740 | 2,324,670 | Shares | Other | 2024-02-14 | |
| 2023-09-30 | $30,925,954 | 1,781,449 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $33,455,632 | 1,607,671 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $40,283,197 | 1,712,721 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $37,649,500 | 1,347,995 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $25,448,670 | 1,087,550 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $71,158,702 | 2,108,406 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $109,035,427 | 3,121,541 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $92,924,630 | 3,051,712 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $71,215,453 | 2,171,865 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $14,887,314 | 491,980 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||